Search

everythinglearnresearchcommunity

for

Search:↓

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

COC treatment improves hormone and metabolic levels in PCOS patients.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Hormones play a key role in skin aging, with estrogen and testosterone declines affecting skin health.

Iris-exosomes may help treat hair loss by activating hair growth pathways.

Lifestyle changes like a healthy diet, exercise, and proper sleep can help manage PCOD.

Identified genes linked to male-pattern baldness may help develop new treatments.

Light exposure is crucial for health, helping prevent and treat illnesses.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Gonadal hormones may influence sex differences in play fighting in animals, but their effect on human spatial behavior is unclear and needs more research.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

Hair graying may be caused by stem cell depletion from stress or melanocyte damage.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

Hair loss in a child was an early sign of Crohn's disease.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Skin changes can reveal serious hormone-related diseases, helping save lives.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Thorough evaluations and conservative management can lead to positive outcomes in pediatric adrenocortical carcinoma.